Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXK5TI
|
||||
| Drug Name |
N-(2-methoxy-5-(trifluoromethyl)phenyl)-4-methyl-3-(3-(pyrimidin-4-yl)pyridin-2-yloxy)benzamide
|
||||
| Synonyms |
CHEMBL220549
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H19F3N4O3
|
||||
| Canonical SMILES |
COc1ccc(cc1NC(=O)c2ccc(C)c(Oc3ncccc3c4ccncn4)c2)C(F)(F)F
|
||||
| InChI |
InChI=1S/C25H19F3N4O3/c1-15-5-6-16(23(33)32-20-13-17(25(26,27)28)7-8-21(20)34-2)12-22(15)35-24-18(4-3-10-30-24)19-9-11-29-14-31-19/h3-14H,1-2H3,(H,32,33)
|
||||
| InChIKey |
ZHGVDHRJPICWON-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.